Identical twin toddlers who presented with severe arthritis helped scientists to identify the first gene mutation that can single-handedly cause a juvenile form of this inflammatory joint disease. By investigating the DNA of individual blood cells of both children and then modelling the genetic defect in a mouse model, the research team led by Adrian Liston (VIB-KU Leuven) was able to unravel the disease mechanism. The findings may help to develop an appropriate treatment as well.
Juvenile idiopathic arthritis is the most common form of all childhood rheumatic diseases. It is defined as arthritis that starts at a young age and persists throughout adulthood, but which does not have a defined cause. Patients present with a highly variable clinical picture, and scientists have long suspected that different combinations of specific genetic susceptibilities and environmental triggers drive the disease.
A single gene mutation
In a new study by researchers at VIB, KU Leuven and UZ Leuven, the cause of juvenile arthritis in a young pair of identical twins was traced back to a single genetic mutation.
“Single-cell sequencing let us track what was going wrong in every cell type in the twin’s blood, creating a link from genetic mutation to disease onset,” explains Dr. Stephanie Humblet-Baron (VIB-KU Leuven), one of the researchers involved in the study. “It was the combination of next generation genetics and immunology approaches that allowed us to find out why these patients were developing arthritis at such a young age.”
Modelling a human disease in mice
Parallel studies in mice confirmed that the gene defect found in the patients’ blood cells indeed led to an enhanced susceptibility to arthritis. Prof. Susan Schlenner (VIB-KU Leuven), first author of the study, stresses the relevance of this approach: “New genetic editing approaches bring mouse research much closer to the patient. We can now rapidly produce new mouse models that reproduce human mutations in mice, allowing us to model the disease of individual patients.”
According to immunology prof. Adrian Liston (VIB-KU Leuven) such insights prove invaluable in biomedical research: “Understanding the cause of the disease unlocks the key to treating the patient.”
From cause to cure
Liston’s team collaborated closely with prof. Carine Wouters (UZ Leuven), who coordinated the clinical aspect of the research: “The identification of a single gene that can cause juvenile idiopathic arthritis is an important milestone. A parallel mouse model with the same genetic mutation is a great tool to dissect the disease mechanism in more detail and to develop more effective targeted therapies for this condition.”
And the young patients? They are relieved to know that scientists found the cause of their symptoms: “We are delighted to know that an explanation has been found for our illness and more so because we are sure it will help other children.”
Thankfully, the youngsters’ arthritis is under good control at th?e moment. Thanks to the new scientific findings, their doctors will be in a much better position to treat any future flare-ups.
Learn more: Identical twins light the way for new genetic cause of arthritis
The Latest on: Juvenile idiopathic arthritis
[google_news title=”” keyword=”juvenile idiopathic arthritis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Juvenile idiopathic arthritis
- Alvotech To Manufacture Its High-concentration Interchangeable Biosimilar To Humira For Quallenton April 30, 2024 at 2:31 am
Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), said, under the recently ...
- Hundreds participate in ‘Walk to Cure Arthritis’ to help find a cureon April 27, 2024 at 1:48 pm
JACKSONVILLE, Fla. – Hundreds of people walked together Saturday at the Jacksonville Arboretum and Botanical Gardens to raise money to find a cure for arthritis. Arthritis means inflammation of the ...
- Biogen's Tofidence Gets Positive CHMP Opinion For Rheumatoid Arthritis,Juvenile Arthritis & COVID-19on April 25, 2024 at 6:48 pm
Biogen Inc. (BIIB) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA ...
- Biogen’s tocilizumab biosimilar Tofidence recommended by CHMP to treat arthritis and COVID-19on April 25, 2024 at 5:00 pm
The intravenously administered monoclonal antibody, developed by Bio-Thera, has been recommended to treat moderate to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis ...
- Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®on April 25, 2024 at 1:05 pm
CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA® CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) ...
- How play helped girl with arthritis to laugh againon April 19, 2024 at 2:50 pm
Ten-year-old Sfiyah was a confident and active child who loved football, rugby and hiking, but her life was turned upside down around Christmas 2021. Her joints began to swell and after months of GP ...
- New Developments in the Management of Juvenile Idiopathic Arthritis-related Uveitison April 17, 2024 at 5:00 pm
Chronic anterior uveitis is the most important extra-articular complication of juvenile idiopathic arthritis. It is more frequent in the early-onset forms, with a higher prevalence in the ...
- Cobb County girl, 11, pushes through the pain of juvenile arthritison April 10, 2024 at 3:04 pm
COBB COUNTY, Ga. - Siya Mogulla, who turns 12 later this month, is playing the violin, something that she could not do for years because of severe joint pain. "My elbows, and maybe my waist, my ...
- Role of Methotrexate in Juvenile Idiopathic Arthritison April 9, 2024 at 5:00 pm
Methotrexate is a cornerstone of therapy worldwide for juvenile idiopathic arthritis, yet there remains vast variability in drug dosing and administration, as well as unpredictable outcomes on the ...
- What is oligoarthritis and who does it affect?on April 7, 2024 at 5:00 pm
Oligoarthritis is the most common type of juvenile idiopathic arthritis (JIA). JIA is the most common type of arthritis affecting children and adolescents. People may also refer to oligoarthritis ...
via Bing News